Claus Braestrup - Saniona AB Independent Chairman of the Board
| SANION Stock | SEK 1.85 0.04 2.12% |
Chairman
Dr. Claus T. Braestrup, M.D. was Independent Member of the Board of Directors of Saniona AB since 2014. He no longer serves as Independent Chairman of the Board of the Company effective as of January 19, 2018. He has held the position since 2014. He is also CoFounder of the Company. He is former EVP for Research and Development, later President and CEO of H. Lundbeck AS. Previously he was Vice President of Pharmaceutical Research, President of the CNS Division, and President of the Diabetes Care Division, respectively, at Novo Nordisk AS and Head of Preclinical Drug Research with Schering AG. He was also CEO of Nordic Biotech General Partner II ApS, Chairman of the Board of Probiodrug AG and Member of the Board of Santaris Pharma AS and Gyros AB. He is Chairman of the Board of Saniona AS and member of the boards of Bavarian Nordic AS, Evolva Holding SA and Evotec AG. He is also CEO of Kastan ApS. He has a Doctorate of Medicine from the University of Copenhagen, where he also for a period was Professor in Neuroscience. He is also graduate in Biochemistry. He is writer and coauthor of 125 scientific publications. since 2018.
| Age | 72 |
| Tenure | 6 years |
| Professional Marks | Ph.D |
| Phone | 45 70 70 52 25 |
| Web | https://www.saniona.com |
Saniona AB Management Efficiency
The company has return on total asset (ROA) of (0.5044) % which means that it has lost $0.5044 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.3844) %, meaning that it generated substantial loss on money invested by shareholders. Saniona AB's management efficiency ratios could be used to measure how well Saniona AB manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 1 records | CHAIRMAN Age | ||
| Jorgen Durban | Anoto Group AB | 62 | |
Management Performance
| Return On Equity | -1.38 | |||
| Return On Asset | -0.5 |
Saniona AB Leadership Team
Elected by the shareholders, the Saniona AB's board of directors comprises two types of representatives: Saniona AB inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Saniona. The board's role is to monitor Saniona AB's management team and ensure that shareholders' interests are well served. Saniona AB's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Saniona AB's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Carl Sundberg, Independent Director | ||
| Leif Andersson, Independent Director | ||
| Edward Saltzman, Director | ||
| Claus Braestrup, Independent Chairman of the Board | ||
| Palle Christophersen, Co-Founder and Chief Scientific Officer | ||
| Janus Larsen, Chief Officer | ||
| deBethizy, Chairman of the Board | ||
| MBA MSc, CoFounder CEO | ||
| Thomas Feldthus, CFO, Executive Vice President | ||
| Joergen Drejer, CEO, Director | ||
| Jorgen Drejer, Chairman Founder | ||
| Karin Nielsen, Chief Officer | ||
| Rami Levin, President | ||
| Anker Lundemose, Independent Director | ||
| Palle MS, Ex Research | ||
| Anita BCom, Chief Officer | ||
| Anna Ljung, Director |
Saniona Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Saniona AB a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.38 | |||
| Return On Asset | -0.5 | |||
| Operating Margin | (19.74) % | |||
| Current Valuation | 155.94 M | |||
| Shares Outstanding | 62.39 M | |||
| Shares Owned By Insiders | 22.91 % | |||
| Shares Owned By Institutions | 20.60 % | |||
| Price To Earning | (176.87) X | |||
| Price To Book | 2.10 X | |||
| Price To Sales | 12.55 X |
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Saniona AB. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Complementary Tools for Saniona Stock analysis
When running Saniona AB's price analysis, check to measure Saniona AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Saniona AB is operating at the current time. Most of Saniona AB's value examination focuses on studying past and present price action to predict the probability of Saniona AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Saniona AB's price. Additionally, you may evaluate how the addition of Saniona AB to your portfolios can decrease your overall portfolio volatility.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |